Analysis of CaM-kinase signaling in cells
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
A change in intracellular free calcium is a common signaling mechanism that modulates a wide array of physiological processes in most cells. Responses to increased intracellular Ca2+ are often mediated by the ubiquitous protein calmodulin (CaM) that upon binding Ca2+ can interact with and alter the functionality of numerous proteins including a family of protein kinases referred to as CaM-kinases (CaMKs). Of particular interest are multifunctional CaMKs, such as CaMKI, CaMKII, CaMKIV and CaMKK, that can phosphorylate multiple downstream targets. This review will outline several protocols we have used to identify which members and/or isoforms of this CaMK family mediate specific cellular responses with a focus on studies in neurons. Many previous studies have relied on a single approach such as pharmacological inhibitors or transfected dominant-negative kinase constructs. Since each of these protocols has its limitations, that will be discussed, we emphasize the necessity to use multiple, independent approaches in mapping out cellular signaling pathways.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The molecular basis of CaMKII function in synaptic and behavioural memory
Lisman, J., Schulman, H., & Cline, H. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn753 · Cited by 1,860 · cited 2×
“Given the fact that in neurons CaMKII comprises approximately 1-2% of total brain protein [13], it seems unlikely that one would be able to express enough of the exogenous dnCaMKII to effective inhibit endogenous CaMKII activity.”
BackgroundHawley, S. A., Pan, D. A., Mustard, K. J., Ross, L., Bain, J., Edelman, A. M., Frenguelli, B. G., & Hardie, D. G. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.05.009 · Cited by 1,589 · cited 1×
“AMP-kinase is a known substrate for CaMKK [64], and SAD-B is activated by CaMKKα phosphorylation at the activation-loop Thr (Thr189) in vitro and in transfected cells [65].”
BackgroundCalmodulin Trapping by Calcium-Calmodulin-Dependent Protein Kinase
Meyer, T., Hanson, P. I., Stryer, L., & Schulman, H. (1992) · Science · doi:10.1126/science.256.5060.1199 · Cited by 637 · cited 17×
“Indeed, when CFP is fused to the C-terminus and YFP to the N-terminus of CaMKII, this construct exhibits a basal FRET signal that is quenched upon activation by Ca2+/CaMbinding and subsequent autophosphorylation of Thr286 which maintains constitutive activity of CaMKII [30].”
BackgroundInfluentialAn activity-regulated microRNA controls dendritic plasticity by down-regulating p250GAP
Wayman, G. A., Davare, M., Ando, H., Fortin, D., Varlamova, O., Cheng, H.-Y. M., Marks, D., Obrietan, K., Soderling, T. R., Goodman, R. H., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803072105 · Cited by 559 · cited 1×
“We have taken advantage of this fact to express both CaMK mutants and our morphological markers (EGFP-MAP2B and mRFP-β-Actin) using this vector (Figure 4)[23, 38, 50, 75, 76].”
MethodSelf-citationWayman, G. A., Impey, S., Marks, D., Saneyoshi, T., Grant, W. F., Derkach, V., & Soderling, T. R. (2006) · Neuron · doi:10.1016/j.neuron.2006.05.008 · Cited by 466 · cited 4×
“Table 1 lists the sequence we have successfully used to inhibit the expression of CaMKs in rat neurons [23, 38, 50, 73].”
BackgroundMethodInfluentialSelf-citationLeonard, A. S., Lim, I. A., Hemsworth, D. E., Horne, M. C., & Hell, J. W. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.3239 · Cited by 385
Structure of the Autoinhibited Kinase Domain of CaMKII and SAXS Analysis of the Holoenzyme
Rosenberg, O. S., Deindl, S., Sung, R.-J., Nairn, A. C., & Kuriyan, J. (2005) · Cell · doi:10.1016/j.cell.2005.10.029 · Cited by 333 · cited 1×
“In the inactive states of the various CaMKs, an autoinhibitory domain is thought to interact with and suppress catalytic elements [28], and this interaction is disrupted upon binding of Ca2+/CaM, thereby achieving kinase activation [29].”
BackgroundFink, C. C., Bayer, K.-U., Myers, J. W., Ferrell, J. E., Schulman, H., & Meyer, T. (2003) · Neuron · doi:10.1016/s0896-6273(03)00428-8 · Cited by 328
An activity-induced microRNA controls dendritic spine formation by regulating Rac1-PAK signaling
Impey, S., Davare, M., Lasiek, A., Fortin, D., Ando, H., Varlamova, O., Obrietan, K., Soderling, T. R., Goodman, R. H., & Wayman, G. A. (2010) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2009.10.005 · Cited by 270
Self-citationOtmakhov, N., Tao-Cheng, J.-H., Carpenter, S., Asrican, B., Dosemeci, A., Reese, T. S., & Lisman, J. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.2350-04.2004 · Cited by 258
Cited by
Ardito, F., Giuliani, M., Perrone, D., Troiano, G., & Muzio, L. L. (2017) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2017.3036 · Cited by 1,336
βCaMKII in Lateral Habenula Mediates Core Symptoms of Depression
Li, K., Zhou, T., Liao, L., Yang, Z., Wong, C., Henn, F., Malinow, R., Yates, J. R., & Hu, H. (2013) · Science · doi:10.1126/science.1240729 · Cited by 411
“It was noteworthy that an infection rate as low as 17 T 3% for AAV-bRNAi or 24 T 3% for AAVbK43Rwas sufficient to achieve these strong antidepressive effects, which suggested that the LHb neural network has little redundancy and that altering the activity of a relatively small percentage of LHb neurons is sufficient t…”
InfluentialInterplay of calcium and cadmium in mediating cadmium toxicity
Choong, G., Liu, Y., & Templeton, D. M. (2014) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2014.01.007 · Cited by 292
Liu, X., & Murray, K. D. (2012) · Epilepsia · doi:10.1111/j.1528-1167.2012.03474.x · Cited by 133
Joseph, A., & Turrigiano, G. G. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.0618-17.2017 · Cited by 94
“…by the triple mutation HMDT308 to DEDD (Wayman et al., 2011); caCaMKIV is constructed with a mutation in the autoinhibitory domain inactivated by the triple mutation HMDT308 to DEDD (Wayman et al., 2011); and Empty Vector (EV) encodes a green fluorescent protein (GFP; Clontech Laboratories).”
BackgroundMethodInfluentialDe novo variants in CAMK 2A and CAMK 2B cause neurodevelopmental disorders
Akita, T., Aoto, K., Kato, M., Shiina, M., Mutoh, H., Nakashima, M., Kuki, I., Okazaki, S., Magara, S., Shiihara, T., et al. (2018) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.528 · Cited by 87
Chain, J. L., Alvarez, K., Mascaro-Blanco, A., Reim, S., Bentley, R., Hommer, R., Grant, P., Leckman, J. F., Kawikova, I., Williams, K., et al. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00564 · Cited by 72
Role of Ca2+/Calmodulin-Dependent Protein Kinase Kinase in Adrenal Aldosterone Production
Nanba, K., Chen, A., Nishimoto, K., & Rainey, W. E. (2015) · Endocrinology · doi:10.1210/en.2014-1782 · Cited by 27
CDK5 Targeting as a Therapy for Recovering Neurovascular Unit Integrity in Alzheimer’s Disease
Posada-Duque, R. A., & Cardona-Gómez, G. P. (2021) · Journal of Alzheimer's Disease · doi:10.3233/jad-200730 · Cited by 14
“During LTP, the phosphorylation of CAMKII and ERK is required for the early activation of CREB and memory formation [143, 171–173], and the decrease in CDK5 following NMDA treatment facilitates the activation of CAMKII, inducing LTP [174].”
Metadata
- Authors
- Wayman, G. A., Tokumitsu, H., Davare, M. A., & Soderling, T. R.
- Venue
- Cell Calcium
- Publisher
- Elsevier BV
- Published
- 2011-07
- Volume
- 50
- Issue
- 1
- Pages
- 1-8
- ISSN
- 0143-4160 (ISSN-L)
- OpenAlex
- W2044425186
- Cited by
- 127
- References
- 14
- FWCI
- 5.05
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.